Sign up to save your podcasts
Or
Share Philips has a serious BrightView recall; FDA expands approval for Boston Scientific SCS
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Philips has a serious BrightView recall; FDA expands approval for Boston Scientific SCS
Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, February 7, 2024.
Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast.
GE HealthCare posted fourth-quarter results this week that beat estimates on Wall Street. Fast Five hosts Sean Whooley and Danielle Kirsh talk about the financial highlights.
A former Tandem chief commercial officer joined Ascensia as president of CGM. Hear who is taking over in this new role and what their responsibilities will be.
Dexcom has launched its new ONE+ CGM system in Europe. Whooley explains what the new system is and how it uses some of the company's other technology.
The FDA expanded its approval for Boston Scientific's spinal cord stimulation to include chronic back pain without prior back surgery. Learn more about the system and the data that supported the expanded indication.
Philips has a serious BrightView recall due to a potential falling component. The Fast Five hosts talk about the reason behind the recall and if there have been any complaints stemming from the recall.
BONUS: Read more from Whooley about Boston Scientific's plan after Farapulse won FDA approval, as well as how catheter design was the key to developing the Farapulse technology.
View all episodes
By MassDeviceWelcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, February 7, 2024.
Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast.
GE HealthCare posted fourth-quarter results this week that beat estimates on Wall Street. Fast Five hosts Sean Whooley and Danielle Kirsh talk about the financial highlights.
A former Tandem chief commercial officer joined Ascensia as president of CGM. Hear who is taking over in this new role and what their responsibilities will be.
Dexcom has launched its new ONE+ CGM system in Europe. Whooley explains what the new system is and how it uses some of the company's other technology.
The FDA expanded its approval for Boston Scientific's spinal cord stimulation to include chronic back pain without prior back surgery. Learn more about the system and the data that supported the expanded indication.
Philips has a serious BrightView recall due to a potential falling component. The Fast Five hosts talk about the reason behind the recall and if there have been any complaints stemming from the recall.
BONUS: Read more from Whooley about Boston Scientific's plan after Farapulse won FDA approval, as well as how catheter design was the key to developing the Farapulse technology.